Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

OPTN

OptiNose (OPTN)

OptiNose Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OPTN
일자시간출처헤드라인심볼기업
2025/02/0801:58Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
2025/01/1521:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2025/01/1521:00GlobeNewswire Inc.Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 MillionNASDAQ:OPTNOptiNose Inc
2024/12/3106:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2024/12/2621:00GlobeNewswire Inc.Optinose Announces 1-for-15 Reverse Stock SplitNASDAQ:OPTNOptiNose Inc
2024/12/2323:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2024/12/1906:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/12/1906:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/12/1723:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
2024/12/1723:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
2024/12/1300:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
2024/12/0306:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPTNOptiNose Inc
2024/12/0305:53GlobeNewswire Inc.Optinose to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
2024/11/2806:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
2024/11/1222:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
2024/11/1221:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2024/11/1221:00GlobeNewswire Inc.Optinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
2024/11/0606:30GlobeNewswire Inc.Optinose Announces Reporting Date for Third Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
2024/10/1903:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
2024/10/1706:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2024/10/1705:05GlobeNewswire Inc.Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OPTNOptiNose Inc
2024/10/0807:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/10/0807:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/10/0805:59GlobeNewswire Inc.Optinose Appoints Terry Kohler as Chief Financial OfficerNASDAQ:OPTNOptiNose Inc
2024/09/2605:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
2024/09/1905:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/09/1905:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
2024/09/1709:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
2024/09/1709:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
2024/09/0522:00GlobeNewswire Inc.New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgeryNASDAQ:OPTNOptiNose Inc
 검색 관련기사 보기:NASDAQ:OPTN